AIMC Topic: Drug Development

Clear Filters Showing 131 to 140 of 318 articles

HGDTI: predicting drug-target interaction by using information aggregation based on heterogeneous graph neural network.

BMC bioinformatics
BACKGROUND: In research on new drug discovery, the traditional wet experiment has a long period. Predicting drug-target interaction (DTI) in silico can greatly narrow the scope of search of candidate medications. Excellent algorithm model may be more...

GEFA: Early Fusion Approach in Drug-Target Affinity Prediction.

IEEE/ACM transactions on computational biology and bioinformatics
Predicting the interaction between a compound and a target is crucial for rapid drug repurposing. Deep learning has been successfully applied in drug-target affinity (DTA)problem. However, previous deep learning-based methods ignore modeling the dire...

Integration of Neighbor Topologies Based on Meta-Paths and Node Attributes for Predicting Drug-Related Diseases.

International journal of molecular sciences
Identifying new disease indications for existing drugs can help facilitate drug development and reduce development cost. The previous drug-disease association prediction methods focused on data about drugs and diseases from multiple sources. However,...

Affinity2Vec: drug-target binding affinity prediction through representation learning, graph mining, and machine learning.

Scientific reports
Drug-target interaction (DTI) prediction plays a crucial role in drug repositioning and virtual drug screening. Most DTI prediction methods cast the problem as a binary classification task to predict if interactions exist or as a regression task to p...

CNN-DDI: a learning-based method for predicting drug-drug interactions using convolution neural networks.

BMC bioinformatics
BACKGROUND: Drug-drug interactions (DDIs) are the reactions between drugs. They are compartmentalized into three types: synergistic, antagonistic and no reaction. As a rapidly developing technology, predicting DDIs-associated events is getting more a...

How paediatric drug development and use could benefit from OMICs: A c4c expert group white paper.

British journal of clinical pharmacology
The safety and efficacy of pharmacotherapy in children, particularly preterms, neonates and infants, is limited by a paucity of good-quality data from prospective clinical drug trials. A specific challenge is the establishment of valid biomarkers. OM...

Graph neural network approaches for drug-target interactions.

Current opinion in structural biology
Developing new drugs remains prohibitively expensive, time-consuming, and often involves safety issues. Accurate prediction of drug-target interactions (DTIs) can guide the drug discovery process and thus facilitate drug development. Non-Euclidian da...

Advancing pharmacy and healthcare with virtual digital technologies.

Advanced drug delivery reviews
Digitalisation of the healthcare sector promises to revolutionise patient healthcare globally. From the different technologies, virtual tools including artificial intelligence, blockchain, virtual, and augmented reality, to name but a few, are provid...

Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a Review.

The AAPS journal
Over the past decade, artificial intelligence (AI) and machine learning (ML) have become the breakthrough technology most anticipated to have a transformative effect on pharmaceutical research and development (R&D). This is partially driven by revolu...

Data Centric Molecular Analysis and Evaluation of Hepatocellular Carcinoma Therapeutics Using Machine Intelligence-Based Tools.

Journal of gastrointestinal cancer
PURPOSE: Computational approaches have been used at different stages of drug development with the purpose of decreasing the time and cost of conventional experimental procedures. Lately, techniques mainly developed and applied in the field of artific...